Wellington Management Group
IRWD icon

Wellington Management Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Wellington Management Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59M Sell
453,515
-50,427
-10% -$207K ﹤0.01% 1592
2025
Q4 		$1.7M Buy
+503,942
New +$1.31M ﹤0.01% 1632
2024
Q3 		– Sell
-109,495
Closed -$714K – 1970
2024
Q2 		$714K Buy
109,495
+14,401
+15% +$102K ﹤0.01% 1737
2024
Q1 		$828K Sell
95,094
-2,324
-2% -$28.2K ﹤0.01% 1722
2023
Q4 		$1.11M Buy
+97,418
New +$964K ﹤0.01% 1607
2023
Q2 		– Sell
-6,178,438
Closed -$65M – 1902
2023
Q1 		$65M Sell
6,178,438
-7,161,939
-54% -$80.2M 0.01% 636
2022
Q4 		$165M Sell
13,340,377
-517,692
-4% -$5.87M 0.03% 423
2022
Q3 		$144M Sell
13,858,069
-1,059,885
-7% -$12M 0.03% 437
2022
Q2 		$172M Sell
14,917,954
-263,693
-2% -$3.11M 0.03% 414
2022
Q1 		$191M Sell
15,181,647
-2,118,658
-12% -$24.3M 0.03% 427
2021
Q4 		$202M Sell
17,300,305
-200,716
-1% -$2.46M 0.03% 444
2021
Q3 		$229M Sell
17,501,021
-3,593,630
-17% -$46.4M 0.04% 408
2021
Q2 		$271M Sell
21,094,651
-94,654
-0.4% -$1.08M 0.05% 375
2021
Q1 		$237M Sell
21,189,305
-428,408
-2% -$4.53M 0.04% 389
2020
Q4 		$246M Sell
21,617,713
-657,441
-3% -$7.19M 0.05% 364
2020
Q3 		$200M Buy
22,275,154
+56,295
+0.3% +$559K 0.04% 363
2020
Q2 		$229M Buy
22,218,859
+154,589
+0.7% +$1.58M 0.05% 322
2020
Q1 		$223M Buy
22,064,270
+340,598
+2% +$4M 0.06% 273
2019
Q4 		$289M Sell
21,723,672
-3,490
-0% -$38.5K 0.06% 306
2019
Q3 		$187M Sell
21,727,162
-541
-0% -$5.26K 0.04% 401
2019
Q2 		$238M Sell
21,727,703
-4,060,105
-16% -$45.5M 0.05% 330
2019
Q1 		$292M Buy
25,787,808
+2,445,895
+10% +$27.3M 0.07% 286
2018
Q4 		$203M Buy
23,341,913
+138,747
+0.6% +$1.59M 0.05% 331
2018
Q3 		$359M Buy
23,203,166
+202,825
+0.9% +$3.21M 0.08% 261
2018
Q2 		$368M Buy
23,000,341
+156,936
+0.7% +$2.32M 0.08% 253
2018
Q1 		$295M Buy
22,843,405
+251,975
+1% +$3.14M 0.07% 291
2017
Q4 		$284M Buy
22,591,430
+48,487
+0.2% +$633K 0.06% 293
2017
Q3 		$298M Buy
22,542,943
+167,754
+0.7% +$2.31M 0.07% 271
2017
Q2 		$354M Buy
22,375,189
+188,814
+0.9% +$2.74M 0.08% 240
2017
Q1 		$317M Buy
22,186,375
+296,725
+1% +$4.06M 0.08% 249
2016
Q4 		$280M Buy
21,889,650
+181,349
+0.8% +$2.29M 0.07% 253
2016
Q3 		$289M Buy
21,708,301
+243,251
+1% +$2.84M 0.07% 256
2016
Q2 		$235M Buy
21,465,050
+160,121
+0.8% +$1.56M 0.06% 280
2016
Q1 		$195M Buy
21,304,929
+77,746
+0.4% +$641K 0.05% 320
2015
Q4 		$206M Buy
21,227,183
+90,336
+0.4% +$873K 0.05% 309
2015
Q3 		$184M Buy
21,136,847
+89,573
+0.4% +$836K 0.05% 317
2015
Q2 		$213M Buy
21,047,274
+117,410
+0.6% +$1.36M 0.05% 307
2015
Q1 		$280M Buy
20,929,864
+286,529
+1% +$3.76M 0.07% 266
2014
Q4 		$265M Buy
20,643,335
+439,296
+2% +$5.03M 0.07% 273
2014
Q3 		$219M Buy
20,204,039
+231,458
+1% +$2.65M 0.06% 303
2014
Q2 		$256M Buy
19,972,581
+98,980
+0.5% +$1.08M 0.07% 300
2014
Q1 		$205M Buy
19,873,601
+3,604,962
+22% +$40.5M 0.06% 339
2013
Q4 		$158M Buy
16,268,639
+334,772
+2% +$3.01M 0.05% 400
2013
Q3 		$158M Buy
15,933,867
+175,233
+1% +$1.72M 0.05% 378
2013
Q2 		$131M Buy
+15,758,634
New +$191M 0.04% 399

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group's IRWD Position: Q1 2026 in Review

Wellington Management Group reduced its Ironwood Pharmaceuticals (IRWD) stake by 10% in Q1 2026, selling an estimated $207K and leaving 453,515 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1592.

Wellington Management Group first reported a position in IRWD in Q2 2013 and has held it in 45 quarters since. The position peaked at $368M in Q2 2018. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Wellington Management Group held 453,515 shares of Ironwood Pharmaceuticals worth $1.59M as of Q1 2026.
  • Wellington Management Group sold 50,427 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $207K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1592 holding.
  • Wellington Management Group first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 45 quarters since.
  • Wellington Management Group's Ironwood Pharmaceuticals position peaked at $368M in Q2 2018.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.